| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S00432-016-2235-Z |
| P698 | PubMed publication ID | 27613187 |
| P50 | author | M Moshahid A Rizvi | Q79776077 |
| P2093 | author name string | Anita K Verma | |
| Aakriti Tyagi | |||
| Ankita Leekha | |||
| Bahadur S Gurjar | |||
| P2860 | cites work | Inactivation of p53 in normal human cells increases G2/M arrest and sensitivity to DNA-damaging agents | Q48040694 |
| Enhanced antitumor activity of vitamin C via p53 in cancer cells. | Q53364763 | ||
| The molecular mechanisms of vitamin C on cell cycle regulation in B16F10 murine melanoma. | Q53557662 | ||
| Hypersusceptibility to cisplatin carcinogenicity in metallothionein-I/II double knockout mice: production of hepatocellular carcinoma at clinically relevant doses. | Q53605266 | ||
| Ascorbic Acid: Biologic Functions and Relation to Cancer | Q55042014 | ||
| Bemerkungen zu der Abhandlung der HH. Weselsky und Benedikt „Ueber einige Azoverbindungen” | Q57483107 | ||
| Role of glycolysis inhibition and poly(ADP-ribose) polymerase activation in necrotic-like cell death caused by ascorbate/menadione-induced oxidative stress in K562 human chronic myelogenous leukemic cells | Q60621763 | ||
| Ascorbic acid (vitamin C) improves the antineoplastic activity of doxorubicin, cisplatin, and paclitaxel in human breast carcinoma cells in vitro | Q71089222 | ||
| The alkaline Comet assay as biomarker in assessment of DNA damage in medical personnel occupationally exposed to ionizing radiation | Q73316632 | ||
| A cross-platform public domain PC image-analysis program for the comet assay | Q78725351 | ||
| Pharmacologic ascorbic acid concentrations selectively kill cancer cells: action as a pro-drug to deliver hydrogen peroxide to tissues | Q24531307 | ||
| Dual effect of oxidative stress on leukemia cancer induction and treatment | Q26866544 | ||
| The controversial place of vitamin C in cancer treatment | Q28298088 | ||
| A simple technique for quantitation of low levels of DNA damage in individual cells | Q29014320 | ||
| Glutathione S-transferases. The first enzymatic step in mercapturic acid formation | Q29547415 | ||
| Mitochondrial free radical generation, oxidative stress, and aging | Q29614202 | ||
| Catalase in vitro | Q29615710 | ||
| The role of p53 in tumour suppression: lessons from mouse models | Q33538155 | ||
| Antiproliferative and apoptotic effects of Sesbania grandiflora leaves in human cancer cells | Q33739831 | ||
| DNA fragmentation in apoptosis | Q34060223 | ||
| Pentoxifylline sensitizes human cervical tumor cells to cisplatin-induced apoptosis by suppressing NF-kappa B and decreased cell senescence. | Q34072134 | ||
| Glutathione conjugation as a bioactivation reaction | Q34129195 | ||
| Mechanisms of resistance to cisplatin | Q34282241 | ||
| Induction of apoptosis and antiproliferative activity of naringenin in human epidermoid carcinoma cell through ROS generation and cell cycle arrest. | Q34351949 | ||
| High-dose vitamin C (ascorbic acid) therapy in the treatment of patients with advanced cancer | Q34979095 | ||
| Cudrania tricuspidata Stem Extract Induces Apoptosis via the Extrinsic Pathway in SiHa Cervical Cancer Cells | Q35951428 | ||
| A new way of measuring apoptosis by absolute quantitation of inter-nucleosomally fragmented genomic DNA. | Q36180179 | ||
| Redox status expressed as GSH:GSSG ratio as a marker for oxidative stress in paediatric tumour patients | Q36424253 | ||
| Role of antioxidants in prophylaxis and therapy: A pharmaceutical perspective | Q36514395 | ||
| Vitamin C selectively kills KRAS and BRAF mutant colorectal cancer cells by targeting GAPDH. | Q36653423 | ||
| Ascorbic acid: chemistry, biology and the treatment of cancer. | Q36717267 | ||
| Biochemical mechanisms of cisplatin cytotoxicity | Q36723866 | ||
| Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries | Q37291430 | ||
| Flow cytometry-based apoptosis detection | Q37393254 | ||
| Tumor suppressive functions of p53 | Q37412688 | ||
| Vitamin C increases the apoptosis via up-regulation p53 during cisplatin treatment in human colon cancer cells | Q39572001 | ||
| Cisplatin cytotoxicity is increased by mifepristone in cervical carcinoma: an in vitro and in vivo study. | Q39793961 | ||
| Release kinetics from bio-polymeric nanoparticles encapsulating protein synthesis inhibitor- cycloheximide, for possible therapeutic applications | Q40430608 | ||
| Apoptosis in mitotic competent undifferentiated cells is induced by cellular redox imbalance independent of reactive oxygen species production | Q40728357 | ||
| Ascorbic acid increases drug accumulation and reverses vincristine resistance of human non-small-cell lung-cancer cells | Q41452271 | ||
| Dual AO/EB staining to detect apoptosis in osteosarcoma cells compared with flow cytometry | Q42017900 | ||
| Oxidative damage to DNA: do we have a reliable biomarker? | Q42428736 | ||
| Evaluation of the genotoxicity of cisplatin, paclitaxel and 5-fluorouracil combined treatment in the Drosophila wing-spot test | Q42930943 | ||
| Anti-angiogenic effect of high doses of ascorbic acid | Q43055596 | ||
| Vitamin C augments chemotherapeutic response of cervical carcinoma HeLa cells by stabilizing P53. | Q43636521 | ||
| Ascorbic acid in the prevention and treatment of cancer. | Q44777064 | ||
| Supplementation with antioxidant micronutrients and chemotherapy-induced toxicity in cancer patients treated with cisplatin-based chemotherapy: a randomised, double-blind, placebo-controlled study | Q44976163 | ||
| L-Ascorbic acid induces apoptosis in acute myeloid leukemia cells via hydrogen peroxide-mediated mechanisms | Q45020039 | ||
| Levels of glutathione, glutathione reductase and glutathione S-transferase activities in rat lung and liver | Q45053341 | ||
| SDS -PAGE and Western Blotting Techniques | Q47769896 | ||
| P433 | issue | 12 | |
| P921 | main subject | cervix uterine cancer | Q160105 |
| vitamin C | Q199678 | ||
| cisplatin | Q412415 | ||
| cell death | Q2383867 | ||
| P304 | page(s) | 2503-2514 | |
| P577 | publication date | 2016-09-09 | |
| P1433 | published in | Journal of Cancer Research and Clinical Oncology | Q2081599 |
| P1476 | title | Vitamin C in synergism with cisplatin induces cell death in cervical cancer cells through altered redox cycling and p53 upregulation | |
| P478 | volume | 142 |
| Q54966942 | Beneficial Effects of Bioactive Compounds in Mulberry Fruits against Cisplatin-Induced Nephrotoxicity. |
| Q90177042 | Cancer prevention programmes in Mexico: are we doing enough? |
| Q55262061 | Effects of 5-hydroxy-4'-nitro-7-propionyloxy-genistein on inhibiting proliferation and invasion via activating reactive oxygen species in human ovarian cancer A2780/DDP cells. |
| Q42371499 | Efficient intracellular delivery makes cancer cells sensitive to nanoemulsive chemodrugs |
| Q59806695 | Oxidative stress: therapeutic approaches for cervical cancer treatment |
| Q50082485 | Redox Paradox: A novel approach to therapeutics-resistant cancer |
| Q94594727 | Renoprotective Effects of a New Free Radical Scavenger, XH-003, against Cisplatin-Induced Nephrotoxicity |
| Q38697702 | The enhanced tumor inhibitory effects of gefitinib and L-ascorbic acid combination therapy in non-small cell lung cancer cells |
| Q40236002 | WP1130 attenuates cisplatin resistance by decreasing P53 expression in non-small cell lung carcinomas |
Search more.